HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
38.69 USD
-0.51 (-1.3%)
Overall HIMS gets a fundamental rating of 5 out of 10. We evaluated HIMS against 100 industry peers in the Health Care Providers & Services industry. HIMS has an average financial health and profitability rating. HIMS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
HIMS has a Return On Assets of 5.99%. This is amongst the best in the industry. HIMS outperforms 83.00% of its industry peers.
HIMS has a Return On Equity of 23.03%. This is amongst the best in the industry. HIMS outperforms 90.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.84%, HIMS is in the better half of the industry, outperforming 61.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 6.05%, HIMS belongs to the best of the industry, outperforming 81.00% of the companies in the same industry.
The Operating Margin of HIMS (5.96%) is better than 64.00% of its industry peers.
HIMS's Gross Margin of 75.01% is amongst the best of the industry. HIMS outperforms 90.00% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
Compared to 5 years ago, HIMS has more shares outstanding
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIMS has an Altman-Z score of 4.55. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.55, HIMS belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HIMS (8.13) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
HIMS's Debt to Equity ratio of 1.67 is on the low side compared to the rest of the industry. HIMS is outperformed by 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4.55 |
ROIC/WACC0.67
WACC8.78%
2.3 Liquidity
A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.88, HIMS is doing good in the industry, outperforming 76.00% of the companies in the same industry.
HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of HIMS (1.64) is better than 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
The Revenue has grown by 78.02% in the past year. This is a very strong growth!
Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.75% yearly.
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 21.08% on average per year.
EPS Next Y-9.33%
EPS Next 2Y10.49%
EPS Next 3Y16.08%
EPS Next 5Y41.75%
Revenue Next Year60.2%
Revenue Next 2Y37.95%
Revenue Next 3Y31.52%
Revenue Next 5Y21.08%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
HIMS is valuated quite expensively with a Price/Earnings ratio of 71.65.
Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
HIMS is valuated expensively when we compare the Price/Earnings ratio to 26.49, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 58.68 indicates a quite expensive valuation of HIMS.
HIMS's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, HIMS is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 71.65 | ||
| Fwd PE | 58.68 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS indicates a slightly more expensive valuation: HIMS is more expensive than 60.00% of the companies listed in the same industry.
HIMS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 73.72 | ||
| EV/EBITDA | 51.53 |
4.3 Compensation for Growth
The decent profitability rating of HIMS may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 16.08% in the coming years.
PEG (NY)N/A
PEG (5Y)1.19
EPS Next 2Y10.49%
EPS Next 3Y16.08%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:HIMS (12/8/2025, 10:38:06 AM)
38.69
-0.51 (-1.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners94.02%
Inst Owner Change15.85%
Ins Owners5.88%
Ins Owner Change-2.93%
Market Cap8.81B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target47.53 (22.85%)
Short Float %32.97%
Short Ratio2.5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-4.55%
PT rev (3m)-7.49%
EPS NQ rev (1m)-32.49%
EPS NQ rev (3m)-66.29%
EPS NY rev (1m)-18.96%
EPS NY rev (3m)-18.37%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 71.65 | ||
| Fwd PE | 58.68 | ||
| P/S | 3.98 | ||
| P/FCF | 73.72 | ||
| P/OCF | 27.09 | ||
| P/B | 15.16 | ||
| P/tB | 69.45 | ||
| EV/EBITDA | 51.53 |
EPS(TTM)0.54
EY1.4%
EPS(NY)0.66
Fwd EY1.7%
FCF(TTM)0.52
FCFY1.36%
OCF(TTM)1.43
OCFY3.69%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)1.19
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.55 |
F-Score3
WACC8.78%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-9.33%
EPS Next 2Y10.49%
EPS Next 3Y16.08%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.2%
Revenue Next 2Y37.95%
Revenue Next 3Y31.52%
Revenue Next 5Y21.08%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.13%
EBIT Next 3Y90.71%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to decline by -9.33% in the next year.